|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Provision for credit losses | |||||
| Provision for foreclosed asset losses | |||||
| Depreciation and amortization | |||||
| Accretion and amortization | |||||
| Other gains, net | |||||
| Gain on sale of subsidiary | |||||
| Loss on sale of securities | |||||
| Net gain on sales of loans | |||||
| Proceeds from sales of loans held for sale | |||||
| Loans originated for sale | |||||
| Deferred income tax expense (benefit) | |||||
| Earnings on bank-owned life insurance | |||||
| Stock-based compensation | |||||
| Change in valuation of mortgage servicing rights | |||||
| Net change in: | |||||
| Accrued interest receivable and other assets | |||||
| Accrued expenses and other liabilities | |||||
| Net cash from operating activities | |||||
| Cash flows from investing activities: | |||||
| Activity in securities available for sale: | |||||
| Purchases | |||||
| Sales | |||||
| Maturities, prepayments, and calls | |||||
| Loan originations and principal collections, net | |||||
| Purchases of premises and equipment | |||||
| Proceeds from sales of premises and equipment | |||||
| Proceeds from sale of subsidiary | |||||
| Capital improvements to foreclosed assets | |||||
| Proceeds from sales of foreclosed assets | |||||
| Net cash from investing activities | |||||
| Cash flows from financing activities: | |||||
| Net change in deposits | |||||
| Net change in short-term borrowings | |||||
| Proceeds from common stock issuance | |||||
| Payments to tax authorities for stock-based compensation | |||||
| Payments made on notes payable and other borrowings | |||||
| Payments made on subordinated debt | |||||
| Cash dividends paid on common stock | |||||
| Payments to repurchase common stock | |||||
| Net cash from financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Beginning cash and cash equivalents | |||||
| Ending cash and cash equivalents | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid on deposits and borrowed funds | |||||
| Income taxes paid | |||||
| Supplemental schedule of noncash activities: | |||||
| Loans transferred to foreclosed assets | |||||
| Premises and equipment transferred to foreclosed assets | |||||
| Additions to mortgage servicing rights | |||||
Loading...